Jamison Private Wealth Management, Inc. Krystal Biotech, Inc. Transaction History
Jamison Private Wealth Management, Inc.
- $602 Billion
- Q2 2024
A detailed history of Jamison Private Wealth Management, Inc. transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Jamison Private Wealth Management, Inc. holds 150 shares of KRYS stock, worth $27,624. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150Holding current value
$27,624% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding KRYS
# of Institutions
266Shares Held
25MCall Options Held
270KPut Options Held
172K-
Black Rock Inc. New York, NY3.95MShares$727 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$528 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.43MShares$448 Million6.1% of portfolio
-
State Street Corp Boston, MA1.33MShares$245 Million0.01% of portfolio
-
Redmile Group, LLC San Francisco, CA1.02MShares$188 Million12.22% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $4.73B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...